• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-08-10

  Azadi and David systematically examined how nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells in a mucus-relevant in vitro model. Their findings identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as major routes and provide a framework for using dynamin perturbation experiments without equating them to a single endocytic pathway.

• EdU Imaging Kits (Cy5) for S-Phase Assays

  2026-08-09

  EdU Imaging Kits (Cy5) combine morphology-preserving click chemistry with Cy5 fluorescence for sensitive proliferation measurements in microscopy and flow cytometry. They are especially useful for testing how JARID2-regulated pathways affect porcine neuroglial-cell proliferation while keeping genotype, transcript, and phenotype measurements in the same experimental framework.

• Partial BACE Inhibition and Synaptic Transmission

  2026-08-08

  Satir et al. tested whether moderate β-secretase inhibition can lower amyloid-β secretion without impairing neuronal communication. Across three BACE inhibitors, Aβ reduction below 50% preserved synaptic transmission in cultured rat cortical neurons, whereas stronger inhibition reduced both measures.

• Dihydroartemisinin: Reliable Cell Assays

  2026-08-07

  A scenario-driven guide to using Dihydroartemisinin SKU N1713 in cell viability, proliferation, and cytotoxicity workflows. It connects formulation control, stock preparation, storage, assay interpretation, and vendor selection to more reproducible laboratory decisions.

• PF-562271 HCl (SKU A8345): Reliable FAK/Pyk2 Inhibition in C

  2026-08-07

  This article presents scenario-driven solutions for real-world cancer research challenges using PF-562271 HCl (SKU A8345), a potent FAK/Pyk2 inhibitor. By integrating validated protocols and literature-backed data, it guides biomedical researchers and lab technicians in optimizing cell-based assays for reproducible, sensitive, and mechanistically insightful results.

• Cabazitaxel (XRP6258) Protocols for Resistant Tumor Models

  2026-08-06

  Cabazitaxel is a semi-synthetic taxane derivative designed to disrupt microtubule dynamics in taxane-resistant and P-glycoprotein-expressing cancer models, where standard chemotherapeutics are ineffective. It is unsuitable for water-based workflows or long-term solution storage, but is optimized for use in DMSO- or ethanol-based experimental systems.

• DiR (DiIC 18 (7)) Optimizes Long-Term Cell Membrane Imaging

  2026-08-06

  DiR (DiIC 18 (7)) enables robust, highly sensitive tracking of cell membranes and extracellular vesicles, supporting advanced therapeutic strategies by overcoming traditional imaging limitations. Its near-infrared properties, minimal cytotoxicity, and long-lasting signal set a new benchmark for membrane labeling in both in vitro and in vivo studies.

• Mc-Val-Cit-PABC-PNP: Practical Guide for ADC Peptide Linker

  2026-08-05

  Mc-Val-Cit-PABC-PNP is a cathepsin-cleavable ADC peptide linker designed for antibody-drug conjugate synthesis requiring selective, lysosomal payload release. This product addresses the need for stability and specificity in organic solvent-based workflows and is not suitable for aqueous, diagnostic, or clinical applications.

• Optimizing Angiogenesis Assays with SU5416 (Semaxanib): SKU

  2026-08-05

  This article addresses common laboratory challenges in angiogenesis, proliferation, and cytotoxicity assays, demonstrating the validated utility and workflow advantages of SU5416 (Semaxanib) (SKU A3847). With evidence-supported guidance and real-world scenario analysis, researchers receive actionable best practices for reproducible results using this selective VEGFR2 tyrosine kinase inhibitor. APExBIO’s formulation and protocol recommendations are highlighted for bench scientists focused on robust, interpretable data.

• Applied Workflows with EdU Imaging Kits (Cy5) for S-Phase DN

  2026-08-04

  EdU Imaging Kits (Cy5) provide a sensitive, morphology-preserving workflow for cell proliferation analysis in both fluorescence microscopy and flow cytometry. Explore practical enhancements, troubleshooting, and translational insights for S-phase studies—outperforming traditional BrdU and advancing genotoxicity and neurogenetic research.

• Ozone Enhances Macrophage Efferocytosis to Relieve Neuropath

  2026-08-04

  This study demonstrates that ozone therapy alleviates neuropathic pain by promoting macrophage efferocytosis via the AMPK/Gas6-MerTK/SOCS3 pathway. The findings offer novel mechanistic insight into apoptotic cell clearance and inflammatory regulation, identifying actionable therapeutic targets for neuropathic pain intervention.

• Engage & Evasion Strategy Boosts EV Therapy via MPS Escape

  2026-08-03

  Liu et al. introduce a dual-step 'Engage & Evasion' approach that enhances extracellular vesicle (EV) therapy for ischemic diseases by minimizing rapid clearance through the mononuclear phagocyte system (MPS). This strategy leverages sequential administration of CD47-modified EVs, significantly improving systemic circulation and tissue targeting.

• IR-1061: Near Infrared Fluorescent Dye for Deep Tissue Imagi

  2026-08-03

  IR-1061 is a near infrared fluorescent dye optimized for in vivo deep tissue imaging with low background and high tissue penetration. Its unique solubility and stability profile make it a robust tool for advanced biomedical research. Benchmarked studies confirm its high emissivity and minimal cytotoxicity under physiological conditions.

• Electrostatic Modulation of α-Synuclein Condensates Revealed

  2026-08-02

  This study demonstrates that α-synuclein (αSyn) condensates formed by liquid–liquid phase separation (LLPS) exhibit strong negative electrostatic potential, critically influencing the partitioning of charged molecules. The findings establish a direct link between condensate surface charge and selective molecular uptake, providing new tools for probing intracellular phase-separated structures and their roles in neurodegenerative disease.

• GSH-Responsive ICG MOF Nanoparticles for Synergistic Melanom

  2026-08-01

  Hao et al. introduce a metal-organic framework (MOF) nanoparticle system that co-delivers indocyanine green and a PD-1 inhibitory peptide with glutathione-responsive release, achieving synergistic photothermal therapy and immunotherapy for melanoma. This approach addresses the limitations of single-mode treatments by enhancing tumor ablation and immune activation, with practical implications for the design of next-generation nanomedicines.

16622 records 2/1109 page Previous Next 12345 下5页 Last page